Review Article
The clinical importance and prognostic implications of microsatellite instability in sporadic cancer

https://doi.org/10.1053/ejso.2002.1399Get rights and content

Abstract

Aims: The genetic abnormality known as microsatellite instability (MSI), first identified in colorectal cancer in 1993, has subsequently been recognised in other malignancies. These cancers are caused by a defect in the nuclear mismatch repair system, allowing mutations to accumulate with every cellular division. Hereditary Non Polyposis Colon Cancers (HNPCC) and associated malignancies demonstrating MSI have a unique histological appearance, improved prognosis and altered response to chemotherapy and radiotherapy. This review examines the incidence of MSI and its clinical significance in commonly occurring solid malignancies.

Method: A medline based literature search was performed using the key words ‘Microsatellite Instability’ and the name of the specific malignancy being investigated. Additional original papers were obtained from citations in those articles identified in the original medline search.

Results: MSI has been detected in many solid malignancies although the definition of instability applied has been variable. It is most commonly found in sporadic malignancies that also occur in the HNPCC syndrome such as colorectal, stomach, endometrial and ovarian cancer. MSI may impart a favorable prognosis in colorectal, gastric, pancreatic and probably oesophageal cancers but a poor prognosis in non small cell lung cancer. In clinical studies colorectal cancers demonstrating MSI respond better to chemotherapy while in vitro studies using MSI positive cell lines show resistance to radiotherapy and chemotherapy.

Conclusion: MSI may be a useful genetic marker in prognosis and could be an influential factor in deciding treatment options. However, in many cancers its significance remains unclear and more evaluation is required.

References (190)

  • HT Lynch et al.

    Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

    Gastroenterology

    (1993)
  • R Dolcetti et al.

    High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability

    Am J Pathol

    (1999)
  • HT Lynch et al.

    Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer

    Med Hypotheses

    (1981)
  • R Sankila et al.

    Better survival rates in patients with MLH1-associated hereditary colorectal cancer

    Gastroenterology

    (1996)
  • MG Tibiletti et al.

    Microsatellite instability in endometrial cancer: relation to histological subtypes

    Gynecol Oncol

    (1999)
  • C Oliveira et al.

    The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different ‘target genes’: a study of the TGFbeta RII, IGFII R, and BAX genes

    Am J Pathol

    (1998)
  • HJ Allen et al.

    Microsatellite instability in ovarian and other pelvic carcinomas

    Cancer Genet Cytogenet

    (2000)
  • YC Shih et al.

    No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms

    Gynecol Oncol

    (1998)
  • JT Lin et al.

    Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages

    Eur J Cancer

    (1995)
  • JD Hayden et al.

    Prognostic significance of microsatellite instability in patients with gastric carcinoma

    Eur J Cancer

    (1997)
  • NR dos Santos et al.

    Microsatellite instability at multiple loci in gastric carcinoma: clinico-pathologic implications and prognosis

    Gastroenterology

    (1996)
  • C Bonnal et al.

    Absence of microsatellite instability in transitional cell carcinoma of the bladder

    Urology

    (2000)
  • Y Ionov et al.

    Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

    Nature

    (1993)
  • SN Thibodeau et al.

    Microsatellite instability in cancer of the proximal colon

    Science

    (1993)
  • LA Aaltonen et al.

    Clues to the pathogenesis of familial colorectal cancer

    Science

    (1993)
  • CR Boland et al.

    A National Cancer Institute Workshop on Microsatellite Instability for cancer detec-tion and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

    Cancer Res

    (1998)
  • S Markowitz et al.

    Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

    Science

    (1995)
  • RF Souza et al.

    Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours

    Nat Genet

    (1996)
  • RF Souza et al.

    Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors

    Cancer Res

    (1997)
  • N Rampino et al.

    Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype

    Science

    (1997)
  • CM Gleeson et al.

    Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia

    Oncogene

    (1996)
  • S Olschwang et al.

    Alternative genetic pathways in colorectal carcinogenesis

    Proc Natl Acad Sci USA

    (1997)
  • I Tomlinson et al.

    Does MSI-low exist?

    J Pathol

    (2002)
  • JR Jass et al.

    Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways

    J Clin Pathol

    (1999)
  • AK Sood et al.

    Application of the National Cancer Institute international criteria for determination of micro- satellite instability in ovarian cancer

    Cancer Res

    (2001)
  • A Percesepe et al.

    Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study

    J Clin Oncol

    (2001)
  • M Aarnio et al.

    Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome

    Int J Cancer

    (1995)
  • HF Vasen et al.

    The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

    Dis Colon Rectum

    (1991)
  • NE Beck et al.

    Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled

    Br J Surg

    (1997)
  • HT Lynch et al.

    Muir–Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome

    Br J Dermatol

    (1985)
  • B Bapat et al.

    The genetic basis of Muir–Torre syndrome includes the hMLH1 locus

    Am J Hum Genet

    (1996)
  • R Honchel et al.

    Microsatellite instability in Muir–Torre syndrome

    Cancer Res

    (1994)
  • SR Hamilton et al.

    The molecular basis of Turcot's syndrome

    N Engl J Med

    (1995)
  • MD Taylor et al.

    The hPMS2 exon 5 mutation and malignant glioma. Case report

    J Neurosurg

    (1999)
  • T Chan et al.

    Germline hMSH2 and differential somatic mutations in patients with Turcot's syndrome

    Genes Chromosomes Cancer

    (1999)
  • F Paraf et al.

    Brain tumor-polyposis syndrome: two genetic diseases?

    J Clin Oncol

    (1997)
  • B Liu et al.

    Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients

    Nat Med

    (1996)
  • VJ Bubb et al.

    Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer

    Oncogene

    (1996)
  • P Watson et al.

    Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members

    Cancer

    (1998)
  • JG Guillem et al.

    Varying features of early age-of-onset ‘sporadic’ and hereditary nonpolyposis colorectal cancer patients

    Dis Colon Rectum

    (1999)
  • Cited by (112)

    • The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method

      2022, Gynecologic Oncology
      Citation Excerpt :

      Moreover, supporting the conclusion of the study of Imboden et al., we established the prognostic value of IHC stratification concerning to 2021 risk classification; it has to be acknowledged that the 3 subgroups received similar adjuvant treatments (15). The prognostic role of MMR deficiency in colorectal cancer has been widely defined: patients with MMR defects have an overall favorable prognosis compared to those with intact MMR expression (24,25). In EC, the clinical value of MMR status is still debated, particularly in early-stage disease (26–29).

    • What is precision medicine in oncology?

      2022, Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology
    • ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: A systematic review-based approach

      2019, Annals of Oncology
      Citation Excerpt :

      MSI is the hallmark of Lynch syndrome and constitutional mismatch repair deficiency (CMMRD). MSI is found in a varying proportion of sporadic cancers that belong to the spectrum of cancer types that occur in this syndrome, including colorectal, endometrial, gastric, small intestine, urothelial, central nervous system and sebaceous gland neoplasms [1–3]. Recent evidence demonstrating that MSI is a predictive biomarker for immunotherapy [4–7] has increased the clinical request from oncologists for dMMR testing on many different cancer types.

    • Parathyroid Growth: Normal and Abnormal

      2015, The Parathyroids: Basic and Clinical Concepts: Third Edition
    View all citing articles on Scopus
    f1

    Correspondence to: Professor P. B. Boulos, Department of Surgery, Royal Free and University College Medical School, University College London, 2nd Floor, Charles Bell House, 67–73 Riding House Street, London, WIW 7EJ, UK. Tel: +442076799317; Fax: +442076799317; E-mail:[email protected]

    View full text